Position in EXEL
as of Mar 31, 2026
· filed Apr 17, 2026
Position Value
$905,450
-$448,984 QoQ
Shares Held
21,111
-31.7% QoQ
Ownership
0.008%
of shares outstanding
% of Portfolio
0.09%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Jun 2025
4 quarters on record
Voting authority
Sole 0.ToString("F0")%
Shared 0.ToString("F0")%
None 100.ToString("F0")%
Common Shares in EXEL Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Mar 31, 2026Krilogy Financial LLC holds $7,643,843 across 19 Biotechnology names. EXEL ranks #3 (11.8% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | INCY |
Incyte Corp
|
27,270 | $2,566,652 | |
| 2 | REGN |
Regeneron Pharmaceuticals, Inc.
|
2,443 | $1,887,559 | |
| 3 | EXEL |
Exelixis, Inc.
This page
|
21,111 | $905,450 | |
| 4 | BMRN |
Biomarin Pharmaceutical Inc
|
14,124 | $797,864 | |
| 5 | SRPT |
Sarepta Therapeutics, Inc.
|
18,845 | $410,067 | |
| 6 | ALNY |
Alnylam Pharmaceuticals, Inc.
|
1,173 | $388,110 | |
| 7 | FTRE |
Fortrea Holdings Inc.
|
18,163 | $171,095 | |
| 8 | CADL |
Candel Therapeutics, Inc.
|
30,065 | $147,318 |
All Filings in EXEL
Export CSV
4 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $905,450 | 21,111 | Shares | Sole | 2026-04-17 | |
| 2025-12-31 | $1,354,434 | 30,902 | Shares | Sole | 2026-01-27 | |
| 2025-09-30 | $849,293 | 20,564 | Shares | Sole | 2025-11-06 | |
| 2025-06-30 | $456,183 | 10,349 | Shares | Sole | 2025-07-09 | |
| No filing history on record for this holder in this stock. | ||||||